#Pharma is slow and risk-averse.
I think pharma is slow and risk-averse. But they are very open and very excited to learn about those opportunities. You just need to know how to talk to them. It's all about communication.Evolution…
Continue ReadingI think pharma is slow and risk-averse. But they are very open and very excited to learn about those opportunities. You just need to know how to talk to them. It's all about communication.Evolution…
Continue ReadingAs part of NVIDIA’s AI Enterprise software available on AWS Marketplace, developers will gain access to an expanding AI model library through standard APIs.This integration with Amazon SageMaker and AWS ParallelCluster is designed to…
Continue ReadingWhat You Should Know:
· Yseop, a world-leading Artificial Intelligence (AI) software company and pioneer in Generative AI, has announced today the development of an enhanced Generative AI application tailored for the Biopharma industry, with…
Continue ReadingSo, if there is a study activity, that can be decentralized, that can be done virtually, why burdening patients to bring them to the hospital? Build that flexibility into the protocol, it will allow…
Continue ReadingWhat You Should Know:
– Security researchers at Nozomi Networks Labs identified three vulnerabilities in the Merge DICOM Toolkit C/C++ SDK (versions prior to v5.18).
– These vulnerabilities could be exploited by attackers to crash medical…
Continue ReadingCan you guess why the French like snails?#startuptips #startups #healthtech #digitalhealth…
Continue ReadingWelcome to the April edition of Digital Health Digest!This month, we bring you a closer look at key developments in the digital health sector, from pediatric telehealth advancements to initiatives supporting health equity. Join…
Continue ReadingWorcestershire Acute Hospitals NHS Trust has implemented new artificial intelligence software that is helping to save the lives of stroke patients by analysing brain images. The RapidAI software analyses brain images to help clinicians…
Continue ReadingIndependent clinical practices are in danger everywhere: if they don’t go out of business, large hospital chains tend to pipette them up. Bill Lucchini, CEO of Nextech, wants these independent practices to survive. Nextech’s…
Continue ReadingIndependent clinical practices are in danger everywhere: if they don't go out of business, large hospital chains tend to pipette them up. Bill Lucchini, CEO of Nextech, wants these independent practices to survive. Nextech's…
Continue Reading